Assessment of Nutritional Status in Cancer – The Relationship Between Body Composition and Pharmacokinetics
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Several nutritional assessment tools have been used in oncology settings to monitor nutritional status and its associated prognostic significance. Body composition is fundamental for the assessment of nutritional status. Recently, the use of accurate and precise body composition tools has significantly added to the value of nutritional assessment in this clinical setting. Computerized tomography (CT) is an example of a technique which provides state-of-the-art assessment of body composition. With use of CT images, a great variability in body composition of cancer patients has been identified even in people with identical body weight or body mass index. Severe muscle depletion (sarcopenia) has emerged as a prevalent body composition phenotype which is predictive of poor functional status, shorter time to tumor progression, shorter survival, and higher incidence of dose-limiting toxicity. Variability in body composition of cancer patients may be a source of disparities in the metabolism of cytotoxic agents. Future clinical trials investigating dose reductions in patients with sarcopenia and dose-escalating studies based on pre-treatment body composition assessment have the potential to alter cancer treatment paradigms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prado, C. M., Lieffers, J. R., McCargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., & Baracos, V. E. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70153-0 · Cited by 3,238
Self-citationSimplified calculation of body surface area
(1987) · New England Journal of Medicine · doi:10.1056/nejm198710223171717 · Cited by 3,238
Mourtzakis, M., Prado, C. M. M., Lieffers, J. R., Reiman, T., McCargar, L. J., & Baracos, V. E. (2008) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h08-075 · Cited by 2,224 · cited 2×
“The advantages and limitations of using DXA and CT methods of body composition analysis have been discussed elsewhere [5, 17] but importantly, DXA cannot differentiate between the different types of fat and non-fat tissues, such as the separation of lean body mass into muscle, organs and especially tumors; and the sep…”
BackgroundSelf-citationSarcopenic Obesity: The Confluence of Two Epidemics
Roubenoff, R. (2004) · Obesity Research · doi:10.1038/oby.2004.107 · Cited by 453 · cited 1×
“An additional concern is the ability of obesity to mask sarcopenia which makes identifying and treating this condition difficult [27, 28].”
BackgroundThe meaning and measurement of lean body mass
Roubenoff, R., & Kehayias, J. J. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1991.tb03013.x · Cited by 218
The advantages and limitations of cross-sectional body composition analysis
MacDonald, A. J., Greig, C. A., & Baracos, V. (2011) · Current Opinion in Supportive & Palliative Care · doi:10.1097/spc.0b013e32834c49eb · Cited by 101 · cited 1×
“However, DXA and CT imaging analysis represent gold standards for evaluating body composition in patients with malignant disease [16-18].”
BackgroundSelf-citation
Cited by
Lean Tissue Imaging: A New Era for Nutritional Assessment and Intervention
Prado, C. M. M., & Heymsfield, S. B. (2014) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607114550189 · Cited by 550
Self-citationHeymsfield, S. B., Gonzalez, M. C., Lu, J., Jia, G., & Zheng, J. (2015) · Proceedings of the Nutrition Society · doi:10.1017/s0029665115000129 · Cited by 483
Sarcopenia and cachexia in the era of obesity: clinical and nutritional impact
Prado, C. M., Cushen, S. J., Orsso, C. E., & Ryan, A. M. (2016) · Proceedings of the Nutrition Society · doi:10.1017/s0029665115004279 · Cited by 300
Self-citationOsteosarcopenic obesity: the role of bone, muscle, and fat on health
Ormsbee, M. J., Prado, C. M., Ilich, J. Z., Purcell, S., Siervo, M., Folsom, A., & Panton, L. (2014) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-014-0146-x · Cited by 257
“In fact, obese individuals may present with depleted muscle mass and strength, similar to emaciated or cachectic patients [1].”
InfluentialSelf-citationCrawford, J., Prado, C. M. M., Johnston, M. A., Gralla, R. J., Taylor, R. P., Hancock, M. L., & Dalton, J. T. (2016) · Current Oncology Reports · doi:10.1007/s11912-016-0522-0 · Cited by 178
“The potential of enobosarm for clinical utility was demonstrated 37 Page 2 of 11 Curr Oncol Rep (2016) 18: 37”
BackgroundMethodInfluentialSelf-citation
Metadata
- Authors
- Prado, C., Maia, Y., Ormsbee, M., Sawyer, M., & Baracos, V.
- Venue
- Anti-Cancer Agents in Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2013-09-01
- Volume
- 13
- Issue
- 8
- Pages
- 1197-1203
- ISSN
- 1568-0118 (ISSN-L)
- 1871-5206
- OpenAlex
- W2101997785
- Cited by
- 84
- References
- 6
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Assessment of Nutritional Status in Cancer – The Relationship Between Body Composition and Pharmacokinetics. https://app.cochat.ai/papers/10.2174/18715206113139990322
- The paper
- Prado, C., Maia, Y., Ormsbee, M., Sawyer, M., & Baracos, V. (2013). Assessment of Nutritional Status in Cancer – The Relationship Between Body Composition and Pharmacokinetics. Anti-Cancer Agents in Medicinal Chemistry. https://doi.org/10.2174/18715206113139990322
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.